fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Lactulose

All products: general benefit

PMS-Lactulose · DIN 00703486 · 667 mg/mL · oral liquid

General benefitDormant since August 1, 2025 · checked October 5, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
No interchangeable product listed in the Ontario extract
PMS-Lactulose · DIN 00703486 Manufacturer: Pharmascience Inc.; listing date 1996-10-01 Health Canada: Dormant since 2025-08-01 · brand PMS-LACTULOSE SYR 667MG/ML · ATC A06AD11 LACTULOSE · form Solution · route Oral · ingredients LACTULOSE 667 MG/ML · company Pharmascience inc · schedule Non-prescription drugs
Re-check Health Canada status and shortages (live) · Health Canada product record

PMS-Lactulose: Formulary list price $0.01 per unit (the source does not state the unit; exact figure $0.0147). What the ministry pays, not the patient.

Ministry pays: $0.0147 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00703486)

Source record
DIN 00703486: PMS-Lactulose Raw flags: sec3=Y Item: 561200047; group id 651; item number 1633; lccId None; manufacturer id PMS Source form: O/L; strength: 667mg/mL Recorded listing: General benefit Source prices (unrounded): $0.0147; ministry $0.0147 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00703486 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=38260
Shortage status: discontinued (November 15, 2021, reported by PHARMASCIENCE INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00703486
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since August 1, 2025 — choose a marketed DIN from the same-category list.

Other products in the same Health Canada class (A06A): coverage varies; not interchangeable

  • Bisacodyl (Dulcolax): general benefit
  • Docusate dioctyl sulfosuccinate (Docusate Sodium): general benefit
  • Citrus fibre + grain (Novo-Fibre): general benefit, not a benefit
  • Citric acid + oxide + picosulfate (Pico-Salax): general benefit
  • Mineral oil (Fleet Enema Mineral Oil): general benefit
Other drugs in the same formulary class (56:12 Cathartics) and how they are covered

Matched class: 56:12 Cathartics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: BISACODYL, DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE), MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE, MINERAL OIL, PSYLLIUM MUCILLOID, SENNOSIDES A & B, SODIUM BIPHOSPHATE & SODIUM PHOSPHATE Some products covered without a code (check the product listing): GRAIN & CITRUS FIBRE 56:12 Cathartics

BISACODYL

· 5 products · General benefit · strengths: 5mg, 10mg · Ent Tab, Sup

DOCUSATE SODIUM (DIOCTYL SODIUM SULFOSUCCINATE)

· 6 products · General benefit · strengths: 100mg, 4mg/mL, 10mg/mL · Cap, O/L

GRAIN & CITRUS FIBRE

· 2 products · General benefit (1), Listed, not a benefit (1) · strengths: · Tab

MAGNESIUM OXIDE & CITRIC ACID & SODIUM PICOSULFATE

· 2 products · General benefit · strengths: 3.5g & 12g & 10mg · Pd for Sol-12g Sachet

MINERAL OIL

· 1 products · General benefit · strengths: 100% · Enema

PSYLLIUM MUCILLOID

· 1 products · General benefit · strengths: · Oral Pd

SENNOSIDES A & B

· 2 products · General benefit · strengths: 8.6mg · Tab

SODIUM BIPHOSPHATE & SODIUM PHOSPHATE

· 2 products · General benefit · strengths: 160mg & 60mg/mL · Ped Rect Sol, Rect Sol (with Preservative) Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 56:12
Full class listing Related classes: 56:04 Antacids and Adsorbents, 56:08 Antidiarrhea Agents, 56:16 Digestants, 56:22 Antiemetics and Antinauseants, 56:40 Miscellaneous G.I. Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no link

Availability

PMS-Lactulose · DIN 00703486 Shortage status: discontinued (2021-11-15, reported by PHARMASCIENCE INC); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00703486

Check this DIN again
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)